Reblozyl 25 mg lyophilized powder for injection Images
Generic Name: luspatercept
This medication has been identified as Reblozyl 25 mg lyophilized powder for injection and is used for Myelodysplastic Syndrome, Anemia, and Beta Thalassemia. It belongs to the drug class miscellaneous erythropoiesis agents and is not a controlled substance.
Images of medication
Reblozyl
- Generic Name
- luspatercept
- Strength
- 25 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous erythropoiesis agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0711
See also:
More about Reblozyl (luspatercept)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.